Nevertheless, the improvements in aerobic capacity, whole body insulin sensitivity, and reduced adiposity in addition to the improvements in blood lipids following 10 weeks of group-based HIT will result in meaningful reductions in cardiovascular and metabolic disease risk. The gene discussed is INS; the disease is Other metabolic disease.